Ilaria Maccora Selected Research

1-(2-chloroethyl)-1-nitrosourea (CNU)

12/2021

A peptide-based anti-Adalimumab antibody assay to monitor immune response to biologics treatment in juvenile idiopathic arthritis and childhood chronic non-infectious uveitis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ilaria Maccora Research Topics

Disease

5	Uveitis 01/2022 - 01/2020
3	Juvenile Arthritis (Juvenile Idiopathic Arthritis) 11/2022 - 12/2021
3	Infections 09/2022 - 05/2021
3	Rheumatic Diseases (Rheumatism) 09/2022 - 06/2020
2	Inflammation (Inflammations) 01/2021 - 01/2020
1	Agammaglobulinemia (Hypogammaglobulinemia) 09/2022
1	Communicable Diseases (Infectious Diseases) 09/2022
1	Graft vs Host Disease (Graft-Versus-Host Disease) 09/2022
1	Heart Arrest (Cardiac Arrest) 08/2022
1	Myositis (Idiopathic Inflammatory Myopathies) 02/2022
1	Tuberculosis (Tuberculoses) 12/2021
1	Disease Progression 12/2021
1	Papilledema 11/2021
1	Retinal Vasculitis 11/2021
1	Retinitis 11/2021
1	Conjunctivitis 11/2021
1	Optic Neuritis (Retrobulbar Neuritis) 11/2021
1	COVID-19 05/2021
1	Aneurysm (Aneurysms) 01/2021
1	Fever (Fevers) 01/2021
1	Arteritis 01/2021
1	Mucocutaneous Lymph Node Syndrome (Kawasaki Disease) 01/2021
1	Sarcoidosis (Schaumann Disease) 03/2020
1	Acquired Immunodeficiency Syndrome (AIDS) 01/2020
1	Overweight 01/2019
1	Rheumatoid Arthritis 01/2019
1	Obesity 01/2019

Drug/Important Bio-Agent (IBA)

5	Adalimumab (Humira)FDA Link 02/2022 - 01/2020
4	Pharmaceutical PreparationsIBA 11/2022 - 05/2021
4	Biological ProductsIBA 02/2022 - 01/2021
3	tocilizumab (atlizumab)FDA Link 02/2022 - 01/2020
2	Methotrexate (Mexate)FDA LinkGeneric 01/2022 - 01/2020
2	Antirheumatic Agents (DMARD)IBA 12/2021 - 01/2021
2	SteroidsIBA 01/2021 - 01/2021
2	Interleukin-1 (Interleukin 1)IBA 01/2021 - 01/2020
2	CytokinesIBA 01/2020 - 01/2019
1	Biosimilar PharmaceuticalsIBA 11/2022
1	Mycophenolic Acid (Cellcept)FDA LinkGeneric 09/2022
1	Immunoglobulin G (IgG)IBA 09/2022
1	Immunoglobulins (Immunoglobulin)IBA 09/2022
1	Infliximab (Remicade)FDA Link 02/2022
1	Etanercept (Enbrel)FDA Link 02/2022
1	Rituximab (Mabthera)FDA Link 02/2022
1	Abatacept (Orencia)FDA Link 01/2022
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2022
1	AntibodiesIBA 12/2021
1	Peptides (Polypeptides)IBA 12/2021
1	1-(2-chloroethyl)-1-nitrosourea (CNU)IBA 12/2021
1	veltuzumabIBA 11/2021
1	Intravenous Immunoglobulins (IVIG)FDA Link 01/2021
1	Adrenal Cortex Hormones (Corticosteroids)IBA 03/2020
1	Genetic Markers (Genetic Marker)IBA 01/2020
1	Biomarkers (Surrogate Marker)IBA 01/2020
1	C-Reactive ProteinIBA 01/2019

Therapy/Procedure

4	Therapeutics 09/2022 - 01/2020
2	Biological Therapy 02/2022 - 01/2020
1	Resuscitation 08/2022
1	Cardiopulmonary Resuscitation (CPR) 08/2022
1	Precision Medicine 02/2022
1	Drug Therapy (Chemotherapy) 12/2021